Erica Barnell, MD ’23, PhD ’23, is leading the next era of cancer detection as co-founder and chief medical and science officer of Geneoscopy. In her story, discover how she and her brother created ColoSense®, the first FDA-approved, noninvasive colorectal cancer screening home test that detects signs of cancer from RNA.
Erica Barnell, MD ’23, PhD ’23

